Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: From 20 to 16 fractions

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages 968-972

  Okada, Tohru ^a   Tsuji, Hiroshi ^a   Kamada, Tadashi ^a   Akakura, Koichiro ^b   Suzuki, Hiroyoshi ^b   Shimazaki, Jun ^b   Tsujii, Hirohiko ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Carbon ion radiotherapy; Hypofractionation; Prostate cancer

Indexed keywords

DISEASES; HEAVY IONS; IONS; PATIENT MONITORING; RADIATION DAMAGE; RADIATION EFFECTS; RADIOTHERAPY; TOXICITY; UROLOGY;

BIOCHEMICAL RELAPSE; CARBON ION RADIOTHERAPY; GENITOURINARY TOXICITIES; HYPOFRACTIONATION; LATE RADIATION TOXICITIES; METHODS AND MATERIALS; OVERALL SURVIVAL RATES; PROSTATE CANCERS;

PATIENT TREATMENT;

PROSTATE SPECIFIC ANTIGEN; CARBON;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; INCIDENCE; ION THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RISK FACTOR; SEMINAL VESICLE; TREATMENT PLANNING; UROGENITAL TRACT DISEASE; ADENOCARCINOMA; AGED; BLOOD; CANCER STAGING; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSTATE TUMOR; RADIATION EXPOSURE; RECTUM; RETROSPECTIVE STUDY; SURVIVAL RATE; UROGENITAL SYSTEM;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARBON; DOSE FRACTIONATION; HEAVY ION RADIOTHERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RECTUM; RETROSPECTIVE STUDIES; SURVIVAL RATE; UROGENITAL SYSTEM;

EID: 84872017712     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.072     Document Type: Article

References (15)

1. Nikoghosyan A, Schulz-Ertner D, Didinger B, et al. Evaluation of therapeutic potential of heavy ion therapy for patients with locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58:89-97.
2. Suzuki M, Kase Y, Yamaguchi H, et al. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams. Int J Radiat Oncol Biol Phys 2000; 48:241-250.
3. Denekamp J, Waites T, Fowler JF, et al. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Oncol Biol Phys 1997; 71:681-694.
4. Koike S, Ando K, Uzawa A, et al. Significance of fractionated irradiation for the biological therapeutic gain of carbon ions. Radiat Prot Dos 2002; 99:405-408.
5. Ando K, Koike S, Uzawa A, et al. Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J Radiat Res 2005; 46: 51-57.
6. Tsujii H, Morita S, Miyamoto T, et al. Preliminary results of phase I/II carbon-ion therapy at the National Institute of Radiological Sciences. J Brachyther Int 1997; 13:1-8.
7. Akakura K, Tsujii H, Morita S, et al. Phase I/II clinical trials of carbon ion therapy for prostate cancer. Prostate 2004; 58:252-258.
8. Tsuji H, Yanagi T, Ishikawa H, et al. Hypofractionated radiotherapy with carbon ion beams prostate cancer. Int J Radiat Oncol Biol Phys 2005; 63:1153-1160.
9. Ishikawa H, Tsuji H, Kamada T, et al. Carbon ion radiation therapy for prostate cancer: Results of a prospective phase II study. Radiother Oncol 2006; 81:57-64.
10. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. New York: Wiley-Liss, Inc; 1997. 170-173.
11. Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999; 44:201-210.
12. Cox JD, Stetz BS, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31:1341-1346.
13. Roach M III, Hanks G, Thames H Jr., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 2006; 65:965-974.
14. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
15. Douglas BG, Fowler JF. The effect of multiple small doses of X rays on skin reactions in the mouse and a basic interpretation. Radiat Res 1976; 66:401-426.